Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Azzolini

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Anesthesia and Analgesia|September 4, 1999
Peribulbar anesthesia with either 0.75% ropivacaine or a 2% lidocaine and 0.5% bupivacaine mixture for vitreoretinal surgery: a double-blinded studyL Gioia, E Prandi, M Codenotti, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|August 1, 1984
Surgical treatments of proliferative vitreoretinopathyA E Jalkh, M P Avila, C L Schepens, et al.
The Journal of Clinical Endocrinology and Metabolism|February 15, 2013
Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single centerM L Tanda, E Piantanida, L Liparulo, et al.
The Journal of Pathology|January 1, 1995
Expression of VE (vascular endothelial)-cadherin and other endothelial-specific markers in haemangiomasI Martìn-Padura, C De Castellarnau, S Uccini, et al.
Journal Francais D'Ophtalmologie|March 1, 2014
[Battery of rockets "Scedosporium Apiospermum" in mycotic keratitis]L Cerri, L Geroli, M Al Oum, et al.
Journal of Endocrinological Investigation|June 12, 2014
Pituitary apoplexy during pregnancy: a rare, but dangerous headacheE Piantanida, D Gallo, V Lombardi, et al.
The Journal of Clinical Endocrinology and Metabolism|October 6, 2012
Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathyL Bartalena, G E Krassas, W Wiersinga, et al.
Journal of Endocrinological Investigation|February 9, 2017
Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves' orbitopathy?L Bartalena, G Veronesi, G E Krassas, et al.
Journal of Endocrinological Investigation|June 1, 2020
Asymmetry indicates more severe and active disease in Graves' orbitopathy: results from a prospective cross-sectional multicentre studyP Perros, M P Žarković, G C Panagiotou, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Anesthesia and Analgesia|September 4, 1999
Peribulbar anesthesia with either 0.75% ropivacaine or a 2% lidocaine and 0.5% bupivacaine mixture for vitreoretinal surgery: a double-blinded studyL Gioia, E Prandi, M Codenotti, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|August 1, 1984
Surgical treatments of proliferative vitreoretinopathyA E Jalkh, M P Avila, C L Schepens, et al.
The Journal of Clinical Endocrinology and Metabolism|February 15, 2013
Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single centerM L Tanda, E Piantanida, L Liparulo, et al.
The Journal of Pathology|January 1, 1995
Expression of VE (vascular endothelial)-cadherin and other endothelial-specific markers in haemangiomasI Martìn-Padura, C De Castellarnau, S Uccini, et al.
Journal Francais D'Ophtalmologie|March 1, 2014
[Battery of rockets "Scedosporium Apiospermum" in mycotic keratitis]L Cerri, L Geroli, M Al Oum, et al.
Journal of Endocrinological Investigation|June 12, 2014
Pituitary apoplexy during pregnancy: a rare, but dangerous headacheE Piantanida, D Gallo, V Lombardi, et al.
The Journal of Clinical Endocrinology and Metabolism|October 6, 2012
Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathyL Bartalena, G E Krassas, W Wiersinga, et al.
Journal of Endocrinological Investigation|February 9, 2017
Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves' orbitopathy?L Bartalena, G Veronesi, G E Krassas, et al.
Journal of Endocrinological Investigation|June 1, 2020
Asymmetry indicates more severe and active disease in Graves' orbitopathy: results from a prospective cross-sectional multicentre studyP Perros, M P Žarković, G C Panagiotou, et al.
Pageof 5